Centre Hospitalier Universitaire (CHU) de Caen

Caen 14033

1 studies enrolling now · 3 studies all time

What they study most

Crohn's Disease, Multiple Myeloma, Non-Small Cell Lung Cancer

Studies at this site

• Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients — Recruiting now
• A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease — Running, not enrolling
• A Study of Daratumumab — Running, not enrolling